It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The association between personal habits and metabolic syndrome (MetS) remains controversial. This study aimed to assess the prevalence of MetS among youths and its association with cigarette, tobacco, opium, and alcohol consumption in the Rafsanjan Youth Cohort Study (RYCS). The current cross-sectional study was based on data from RYCS, as part of the Rafsanjan Cohort Study (RCS). RCS is a branch of the prospective epidemiological research studies in Iran (PERSIAN). In the present study, 2843 youths aged 15–35 were included. MetS was diagnosed using the international diabetes federation (International IDF), National Cholesterol Education Panel- Adult Treatment Panel III (NCEP-ATPIII), and Iranian criteria (IDF Iranian). Binary logistic regression models were performed to estimate odds ratios (ORs) and confidence intervals (CIs). The prevalence of MetS was 7.67%, 7.14%, and 10.13% based on NCEP-ATPIII, IDF Iranian, and International IDF criteria respectively. The odds of MetS according to international IDF and Iranian IDF in the alcohol-drinking group in the last 12 months (OR: 1.51, 95%CI 1.02–2.21, OR: 1.66, 95%CI 1.11–2.48 respectively) were greater compared with the non-drinking group. The odds of having high TG in the alcohol-drinking group in the last 12 months was 1.53 times higher than the control group (OR = 1.53, 95% CI: 1.20–1.94). Furthermore, the odds of having high waist circumference (WC) according to IDF International was significantly higher in the tobacco-smoking group in the last 12 months and in the tobacco-smoking group in the last 12 months daily (OR: 1.23, 95%CI 1.01–1.49 and OR: 1.41, 95%CI 1.01–1.98 respectively) compared to the control groups. The prevalence of MetS was 7.67%, 7.14%, and 10.13% based on NCEP-ATPIII, IDF Iranian, and International IDF criteria respectively. The odds of MetS and high TG were greater in the alcohol-drinking group in the last 12 months compared with the non-drinking group. The odds of high WC in the last 12 months, were greater in the tobacco-smoking group compared with the non-smoking group. However, more longitudinal studies are needed to verify the associations observed in the current study.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Niknafs Hospital, Rafsanjan University of Medical Sciences, Clinical Research Development Unit (CRDU), Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
2 Occupational Safety and Health Research Center, NICICO, World Safety Organization and Rafsanjan University of Medical Sciences, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Moradi Hospital, Rafsanjan University of Medical Sciences, Clinical Research Development Unit (CRDU), Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
3 Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Department of Clinical Biochemistry, School of Medicine, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
4 Shahid Sadoughi University of Medical Sciences, Department of Psychiatry, Fellowship of Neuropsychiatry, Research Center of Addiction and Behavioral Sciences, Yazd, Iran (GRID:grid.412505.7) (ISNI:0000 0004 0612 5912)
5 Ali-Ibn Abi-Talib Hospital (CRDU), Rafsanjan University of Medical Sciences, Clinical Research Development Unit, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Department of Internal Medicine, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
6 Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Department of Internal Medicine, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)
7 Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183); Rafsanjan University of Medical Sciences, Department of Epidemiology, School of Public Health, Rafsanjan, Iran (GRID:grid.412653.7) (ISNI:0000 0004 0405 6183)